Potentially Deformed Lyrica Capsules Lead to Recall from Pfizer

Potentially Deformed Lyrica Capsules Lead to Recall from Pfizer
Image: NCCC
January 27, 2016

Pfizer Inc. is issuing a voluntary recall for certain lots of Lyrica due to the potential presence of deformed or damaged capsules.

The recall applies to lot numbers M07861, M07862, and M07865. All bottles contain 90 capsules of 50 or 75 mg strength. An expiration date of 05/01/2018 or 06/01/2018 appears on the packaging.

Despite the potentially jarring appearance of a deformed capsule, Pfizer is assuring patients that these lots are unlikely to cause adverse health consequences.

Lyrica is marketed as a treatment option for individuals suffering from symptoms often associated with fibromyalgia.

The company is immediately ceasing distribution of the affected lots and is instructing customers to return the product. Reimbursement will be made in the form of credit.

Customers with questions about this recall can contact Pfizer at (800) 533-4535.